https://www.fiercebiotech.com/biotech/merck-kgaa-pays-85m-commercialize-abbiskos-rare-tumor-drug-wake-phase-3-win
Merck Group pays $85M for global rights to Abbisko's tumor drug
Apr 1, 2025 - With the CSF-1R inhibitor space heating up, Merck KGaA has gone all-in on pimicotinib, paying Abbisko $85 million for the global license.
merck groupglobal rights
https://www.xing.com/profile/Michael_Huber015934
Michael Huber - Vertrieb - Merck Group | XING
Michael Huber, Darmstadt Professional experience, contact details, portfolio, etc.: Find out more or get in touch with Michael Huber on XING.
michael hubermerck groupvertriebxing
https://theorg.com/org/merck-group?person=anke-graff
Merck Group | The Org
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics.
merck group
https://www.calcalistech.com/ctech/articles/0,7340,L-3731393,00.html
Merck Group Inaugurates Jerusalem Innovation Lab - CTech
Feb 7, 2018 - The new lab is located at Merck subsidiary Qlight Nanotech, acquired by the pharmaceutical company in 2015
merck groupinnovation labjerusalemctech
https://www.finanzen.net/analyse/merck_buy-goldman_sachs_group_inc__1072877
Merck Buy (Goldman Sachs Group Inc.) 16.04.2026 | Analyse | finanzen.net
Merck Buy (Goldman Sachs Group Inc.) 16.04.2026 | Analyse | finanzen.net
goldman sachs group inc